By Carey Gillam Three years ago this month Monsanto executives realized they had a big problem on their hands. It was September 2014 and the company’s top-selling chemical, the weed killer called glyphosate that is the foundation for Monsanto’s branded Roundup products, had been selected as one among a handful of pesticides to undergo scrutiny … How Monsanto Manufactured ‘Outrage’ at IARC over Cancer Classification
A lawyer for a woman claiming her use of Roundup herbicide caused her to develop non-Hodgkin lymphoma sparred with a longtime Monsanto scientist in court on Wednesday, forcing the scientist to address numerous internal corporate documents about research showing Monsanto weed killers could be genotoxic and lead to cancer. The testimony by former Monsanto scientist … Cancer patient lawyer spars with Monsanto scientist in California Roundup trial
For those wanting more details on the reasoning and ramifications of a federal court judge’s decision to limit large volumes of evidence related to Monsanto’s internal communications and conduct from the first federal trial, this transcript of the Jan. 4 hearing on the matter is informative. Here is an exchange between plaintiff’s attorney Brent Wisner … More Details on Limits Too Large Volumes of Evidence
( Transcript of today’s proceedings) Plaintiff Edwin Hardeman took the stand today to offer more testimony in his lawsuit against Monsanto over claims his use of the company’s Roundup herbicide caused him to develop non-Hodgkin lymphoma. Hardeman already testified in the first phase of the trial, which drew a unanimous jury verdict finding that Roundup … Cancer Victim Headed Back to the Stand
